Skip to main content
. 2016 Dec 9;8(5):7710–7721. doi: 10.18632/oncotarget.13846

Table 2. Relation between STAT3 expression level and the clinicopathologic characteristics of ICC patients.

Variable STAT3 expression
Low (0, 1)n = 83 High (2, 3) n = 76 P value
Age (years)* 50 (29–77) 52 (32–70) 0.30#
Sex, M:F 67:16 60:16 0.78
Total bilirubin (umol/L)* 13 (6–438) 13(7–38) 0.18
ALB (g/L)* 43 (27–52) 43(29–52) 0.89
ALT (u/L)* 28(6–132) 34(5–129) 0.81
AST (u/L)* 30(12–113) 33.5(9–111) 0.31
AFP (μg/L), < 20:≥ 20 68:15 53:23 0.07
CA19-9, ≤ 37:> 37 U/ml 36:47 27:49 0.31
CEA, ≤ 5:> 5 ng/ml 29:54 24:52 0.65
HBeAg, positive: negative 15:68 18:58 0.38
HBsAg, positive: negative 46:37 40:36 0.72
HCV, positive: negative 15:68 13:63 0.87
Diameter (cm), ≤ 3: 3–5: > 5 25:25:33 12:20:44 0.04
Tumor number, single: multiple 70:13 61:15 0.50
Pathological satellite, yes: no 23:60 33:43 0.04
Encapsulation, complete: no 14:69 10:66 0.92
Vascular invasion, yes: no 25:58 35:41 0.04
Cirrhosis, yes: no 58:25 50:26 0.58
Differentiation, I:II:III:IV 17:56:8:2 7:43:19:7 0.01
Lymph node metastasis, yes: no 12:71 29:47 0.00
TNM stage, I–II: III–IV 64:19 42:34 0.00
*

Median (range). #Mann-Whitney test.

Note: P < 0.05 by Chi-square test or Student t test